Condensed Consolidated Statements of Earnings (Loss) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|||
| Revenues | ||||||
| Total revenues | $ 226,771 | $ 192,103 | $ 653,534 | $ 507,380 | ||
| Costs and expenses | ||||||
| Cost of revenues | [1] | 27,018 | 18,965 | 84,078 | 51,555 | |
| Research and development | 25,756 | 29,366 | 94,657 | 78,408 | ||
| Selling, general and administrative | 128,056 | 179,678 | 386,866 | 363,173 | ||
| Amortization of intangible assets | 23,221 | 24,325 | 74,198 | 64,930 | ||
| Impairment charges | 1,541 | 0 | 56,460 | 0 | ||
| Contingent consideration loss | 0 | 0 | 2,391 | 7,660 | ||
| Total costs and expenses | 205,592 | 252,334 | 698,650 | 565,726 | ||
| Operating earnings (loss) | 21,179 | (60,231) | (45,116) | (58,346) | ||
| Other income (expense) | ||||||
| Interest and other income, net | 2,248 | 2,277 | 7,260 | 11,230 | ||
| Interest expense | (718) | 0 | (3,033) | 0 | ||
| Total other income, net | 1,530 | 2,277 | 4,227 | 11,230 | ||
| Earnings (loss) before income taxes | 22,709 | (57,954) | (40,889) | (47,116) | ||
| Income tax expense (benefit) | 1,796 | (12,837) | (1,138) | (12,671) | ||
| Net earnings (loss) | $ 20,913 | $ (45,117) | $ (39,751) | $ (34,445) | ||
| Earnings (loss) per share | ||||||
| Basic (in dollars per share) | $ 0.36 | $ (0.80) | $ (0.69) | $ (0.61) | ||
| Diluted (in dollars per share) | $ 0.35 | $ (0.80) | $ (0.69) | $ (0.61) | ||
| Weighted average shares outstanding | ||||||
| Basic (in shares) | 58,202,474 | 56,552,741 | 57,975,499 | 56,133,918 | ||
| Diluted (in shares) | 59,471,021 | 56,552,741 | 57,975,499 | 56,133,918 | ||
| Net product sales | ||||||
| Revenues | ||||||
| Total revenues | $ 178,576 | $ 168,542 | $ 495,042 | $ 468,525 | ||
| Collaboration revenue (ZURZUVAE) | ||||||
| Revenues | ||||||
| Total revenues | 41,697 | 20,164 | 104,690 | 20,164 | ||
| Royalty, licensing, and other revenues | ||||||
| Revenues | ||||||
| Total revenues | $ 6,498 | $ 3,397 | $ 53,802 | $ 18,691 | ||
| ||||||
| X | ||||||||||
- Definition EPS Basic And Diluted No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in value of liability in contingent consideration arrangement in business combination, including, but not limited to, difference arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss for finite- and indefinite-lived intangible assets and capitalized cost for software to be sold, leased, or marketed. Excludes goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|